Pauline Phuong Huynh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pauline Phuong Huynh has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Seth Shay Martin
Johns Hopkins University School of Medicine
11 shared publications - Francoise Adeline Marvel
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins School of Medicine, 1800 Orleans Street, Baltimore, MD, 21287, USA
10 shared publications - Rongzi Shan
Johns Hopkins University School of Medicine, Baltimore, MD, United States
9 shared publications - Erin M. Spaulding
Center for Cardiovascular and Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD, USA; Digital Health Innovation Laboratory, Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
8 shared publications - Helen Xun
Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
7 shared publications Nancy Jiang
Division of Laryngology, Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, United States of America
7 shared publications
Latest Publications
- 15 October 2026
- Published by The Permanente Federation in The Permanente Journal
- p. 1-10
A Bibliometric Analysis of Research Interest in Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis
- 15 October 2026
- Published by The Permanente Federation in The Permanente Journal
- p. 1-10
A Bibliometric Analysis of Research Interest in Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis
- 1 October 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
From Documentation to Recommendation: Is AI a Helper or Healer in the Exam Room?
- 1 October 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
From Documentation to Recommendation: Is AI a Helper or Healer in the Exam Room?
- Open Access
- 11 September 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e91767
Digital Health Use and Interest in Virtual Cardiac Rehabilitation Among Cardiac Inpatients: Cross-Sectional Study
Background: Cardiac rehabilitation (CR) improves patient quality of life, morbidity, and mortality. Unfortunately, it is underused by patients. Digital health interventions offer a solution to increase participation in CR. However, patients’ interest in virtual CR, especially among those in the inpatient setting, has not been fully explored. The benefits of CR have been predominantly demonstrated in traditional, center-based CR programs. Objective: The objective of this cross-sectional study with prospective enrollment was to explore inpatient interest in virtual CR among adult patients who were hospitalized with a CR-qualifying diagnosis. Methods: A Qualtrics survey comprising multiple-choice questions was administered to cardiac inpatients at the progressive cardiac care unit at the Johns Hopkins Hospital from January 2020 to March 2024. Sociodemographic and clinical characteristics were retrieved from the electronic medical records. The study included English-speaking patients aged 18 years or older with a diagnosis eligible for CR. Digital health use was compared between an earlier enrollment period (2020‐2022) and a later enrollment period (2023‐2024). Results: A total of 150 patients were included (mean age 64, SD 13 years; n=57, 38% female, and n=85, 56.7% White). With respect to sociodemographic characteristics, 26% (n=39) of the patients had a high school education or less, 53.8% (70/130) were married, 26.2% (34/130) were employed full time, and 63.8% (83/130) had private insurance. In exploratory enrollment-period comparisons, texting health care providers was more commonly reported in 2023 to 2024 than in 2020 to 2022 (74/123, 60.2% vs 6/27, 22.2%; P <.001), as was using a smartphone or tablet to learn about illnesses (93/123, 75.6% vs 17/27, 63%; P =.04) and to discuss health with a physician or nurse practitioner (86/123, 69.9% vs 12/27, 44.4%; P =.01). Participants with more than a high school education were more likely to perceive smartphones as beneficial for leading a healthier lifestyle (50/104, 48.1% vs 9/37, 24.3%, P =.01) and learning about illnesses (90/105, 85.7% vs 20/37, 54.1%, P <.001) than were participants with a high school education or less. Participants across all sociodemographic factors expressed interest in virtual CR (overall 107/150, 71.3%), with non-White participants being more interested than White participants (55/65, 84.6% vs 52/85, 61.2%, P =.002). Conclusions: Most cardiac inpatients expressed interest in home-based or virtual CR to alleviate barriers to in-person CR participation. Future work should emphasize digital equity and user support to optimize the widespread adoption of virtual CR.
- 11 September 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e91767
Open AccessDigital Health Use and Interest in Virtual Cardiac Rehabilitation Among Cardiac Inpatients: Cross-Sectional Study
Background: Cardiac rehabilitation (CR) improves patient quality of life, morbidity, and mortality. Unfortunately, it is underused by patients. Digital health interventions offer a solution to increase participation in CR. However, patients’ interest in virtual CR, especially among those in the inpatient setting, has not been fully explored. The benefits of CR have been predominantly demonstrated in traditional, center-based CR programs. Objective: The objective of this cross-sectional study with prospective enrollment was to explore inpatient interest in virtual CR among adult patients who were hospitalized with a CR-qualifying diagnosis. Methods: A Qualtrics survey comprising multiple-choice questions was administered to cardiac inpatients at the progressive cardiac care unit at the Johns Hopkins Hospital from January 2020 to March 2024. Sociodemographic and clinical characteristics were retrieved from the electronic medical records. The study included English-speaking patients aged 18 years or older with a diagnosis eligible for CR. Digital health use was compared between an earlier enrollment period (2020‐2022) and a later enrollment period (2023‐2024). Results: A total of 150 patients were included (mean age 64, SD 13 years; n=57, 38% female, and n=85, 56.7% White). With respect to sociodemographic characteristics, 26% (n=39) of the patients had a high school education or less, 53.8% (70/130) were married, 26.2% (34/130) were employed full time, and 63.8% (83/130) had private insurance. In exploratory enrollment-period comparisons, texting health care providers was more commonly reported in 2023 to 2024 than in 2020 to 2022 (74/123, 60.2% vs 6/27, 22.2%; P <.001), as was using a smartphone or tablet to learn about illnesses (93/123, 75.6% vs 17/27, 63%; P =.04) and to discuss health with a physician or nurse practitioner (86/123, 69.9% vs 12/27, 44.4%; P =.01). Participants with more than a high school education were more likely to perceive smartphones as beneficial for leading a healthier lifestyle (50/104, 48.1% vs 9/37, 24.3%, P =.01) and learning about illnesses (90/105, 85.7% vs 20/37, 54.1%, P <.001) than were participants with a high school education or less. Participants across all sociodemographic factors expressed interest in virtual CR (overall 107/150, 71.3%), with non-White participants being more interested than White participants (55/65, 84.6% vs 52/85, 61.2%, P =.002). Conclusions: Most cardiac inpatients expressed interest in home-based or virtual CR to alleviate barriers to in-person CR participation. Future work should emphasize digital equity and user support to optimize the widespread adoption of virtual CR.
- Open Access
- 16 April 2026
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 47 (3) , 104837
30-Day outcomes and opioid prescriptions following outpatient rigid endoscopic Zenker's diverticulectomy and cricopharyngeal myotomy
- 16 April 2026
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 47 (3) , 104837
Open Access30-Day outcomes and opioid prescriptions following outpatient rigid endoscopic Zenker's diverticulectomy and cricopharyngeal myotomy
- Open Access
- 13 January 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (3) , 682-687
Use of mobile health technology in the assessment of statin-associated muscle symptoms: A pilot feasibility study
- 13 January 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (3) , 682-687
Open AccessUse of mobile health technology in the assessment of statin-associated muscle symptoms: A pilot feasibility study
- 27 October 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1792-1799
Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries
Objective(s): To characterize utilization patterns of laryngeal injection procedures (augmentation and therapeutic) and medialization thyroplasty from 2012 to 2022, with particular attention to practice setting, bilateral procedures, and impact of the 2017 Healthcare Common Procedure Coding System (HCPCS) update. Methods: The Centers for Medicare and Medicaid Services (CMS) Physician/Supplier Procedure Summary (PSPS) Master dataset from 2012 to 2022 was utilized in this analysis. HCPCS codes specific for vocal fold injections (e.g., 31513, 31570, 31571, 31573, 31574) and thyroplasty procedures (e.g., 31588, 31591) were evaluated. The number of procedures performed, place of service, and specialty were recorded. Results: Total laryngeal procedures increased by 44.7% from 2012 through 2022, including a 52.3% increase in injections and an 11.9% decrease in thyroplasty. Laryngeal injection procedures increased across all practice settings, with a notable trend toward office‐based procedures (20% to 28%). In contrast, the proportion of laryngeal injection procedures in the hospital and ambulatory surgical center settings decreased from a height of 70%–60% and 17%–13%, respectively. Bilateral procedures increased by 165%, including a 121% increase in bilateral injection augmentation (code 31574). Conclusion: Between 2012 and 2022, total laryngeal procedures increased across all practice settings, with a trend toward more injection laryngoplasty, particularly in the office setting. The growth of bilateral procedures, particularly injection augmentation, suggests a growing demand to treat bilateral presbylarynx. Level of Evidence: 4.
- 27 October 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1792-1799
Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries
Objective(s): To characterize utilization patterns of laryngeal injection procedures (augmentation and therapeutic) and medialization thyroplasty from 2012 to 2022, with particular attention to practice setting, bilateral procedures, and impact of the 2017 Healthcare Common Procedure Coding System (HCPCS) update. Methods: The Centers for Medicare and Medicaid Services (CMS) Physician/Supplier Procedure Summary (PSPS) Master dataset from 2012 to 2022 was utilized in this analysis. HCPCS codes specific for vocal fold injections (e.g., 31513, 31570, 31571, 31573, 31574) and thyroplasty procedures (e.g., 31588, 31591) were evaluated. The number of procedures performed, place of service, and specialty were recorded. Results: Total laryngeal procedures increased by 44.7% from 2012 through 2022, including a 52.3% increase in injections and an 11.9% decrease in thyroplasty. Laryngeal injection procedures increased across all practice settings, with a notable trend toward office‐based procedures (20% to 28%). In contrast, the proportion of laryngeal injection procedures in the hospital and ambulatory surgical center settings decreased from a height of 70%–60% and 17%–13%, respectively. Bilateral procedures increased by 165%, including a 121% increase in bilateral injection augmentation (code 31574). Conclusion: Between 2012 and 2022, total laryngeal procedures increased across all practice settings, with a trend toward more injection laryngoplasty, particularly in the office setting. The growth of bilateral procedures, particularly injection augmentation, suggests a growing demand to treat bilateral presbylarynx. Level of Evidence: 4.
- 17 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (12) , 4571-4577
Arthritis‐Related Adverse Reactions of Dupilumab in Treatment of Chronic Rhinosinusitis
Objective: To investigate the incidence and risk factors for dupilumab‐associated‐arthritis (DAA) in chronic rhinosinusitis with nasal polyps (CRSwNP) and compare DAA prevalence across asthma and atopic dermatitis (AD) using the FDA Adverse Event Reporting System (FAERS). Methods: We queried FAERS from January 2020 to June 2024. Reports were stratified by treatment indication (CRSwNP, asthma, AD). DAA events included arthralgia, arthritis, tenosynovitis, and related musculoskeletal conditions. Multivariable logistic regression assessed associations between DAA and sex, age, and indication. Disproportionality analysis (DPA) via OpenVigil‐FDA evaluated whether DAA was more frequently reported compared with other drugs. Results: Among 207,370 dupilumab‐associated reports, 5055 (2.4%) were DAA‐related. Prevalence was highest in CRSwNP (11.2%), followed by asthma (8.7%) and AD (4.7%). Logistic regression revealed increased DAA odds in CRSwNP (OR 1.81, p < 0.001) and asthma (OR 1.27, p < 0.001), and decreased odds in AD (OR 0.87, p = 0.01). Adults ≥ 50 exhibited elevated risk across all groups. DPA demonstrated DAA was more commonly reported in CRSwNP (ROR 1.92) and asthma (ROR 1.49) compared to all other drugs. AD and CRSwNP patients exhibited elevated risk (OR 3.21, p < 0.001). Conclusion: DAA is more frequent in patients treated for CRSwNP and asthma compared to AD. Older age and coexisting type‐2 inflammatory conditions are associated with increased risk. Clinicians should counsel patients regarding musculoskeletal symptoms and monitor for joint‐related AEs during dupilumab therapy, particularly in CRSwNP treatment. Limitations of FAERS include the presence of reporting bias causing the potential for DAA to be underreported, as well as the inability to calculate its incidence. Level of Evidence: 3.
- 17 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (12) , 4571-4577
Arthritis‐Related Adverse Reactions of Dupilumab in Treatment of Chronic Rhinosinusitis
Objective: To investigate the incidence and risk factors for dupilumab‐associated‐arthritis (DAA) in chronic rhinosinusitis with nasal polyps (CRSwNP) and compare DAA prevalence across asthma and atopic dermatitis (AD) using the FDA Adverse Event Reporting System (FAERS). Methods: We queried FAERS from January 2020 to June 2024. Reports were stratified by treatment indication (CRSwNP, asthma, AD). DAA events included arthralgia, arthritis, tenosynovitis, and related musculoskeletal conditions. Multivariable logistic regression assessed associations between DAA and sex, age, and indication. Disproportionality analysis (DPA) via OpenVigil‐FDA evaluated whether DAA was more frequently reported compared with other drugs. Results: Among 207,370 dupilumab‐associated reports, 5055 (2.4%) were DAA‐related. Prevalence was highest in CRSwNP (11.2%), followed by asthma (8.7%) and AD (4.7%). Logistic regression revealed increased DAA odds in CRSwNP (OR 1.81, p < 0.001) and asthma (OR 1.27, p < 0.001), and decreased odds in AD (OR 0.87, p = 0.01). Adults ≥ 50 exhibited elevated risk across all groups. DPA demonstrated DAA was more commonly reported in CRSwNP (ROR 1.92) and asthma (ROR 1.49) compared to all other drugs. AD and CRSwNP patients exhibited elevated risk (OR 3.21, p < 0.001). Conclusion: DAA is more frequent in patients treated for CRSwNP and asthma compared to AD. Older age and coexisting type‐2 inflammatory conditions are associated with increased risk. Clinicians should counsel patients regarding musculoskeletal symptoms and monitor for joint‐related AEs during dupilumab therapy, particularly in CRSwNP treatment. Limitations of FAERS include the presence of reporting bias causing the potential for DAA to be underreported, as well as the inability to calculate its incidence. Level of Evidence: 3.
- Open Access
- 16 June 2025
- Published by The Permanente Federation in The Permanente Journal
- Vol. 29 (2) , 30-40
Prognosis of Audiologic Recovery From Sudden Sensorineural Hearing Loss Following Corticosteroid Intervention: A Retrospective Chart Review Across Multiple Outcome Measures
This study aimed to evaluate associations among pretreatment hearing deficit, corticosteroid intervention, and audiologic recovery among patients presenting with sudden sensorineural hearing loss within an integrated health system. Electronic health records within a multicenter integrated health system were queried for clinical encounters with a diagnosis of sudden sensorineural hearing loss in 2021. Patient demographics, audiometric data, and therapeutic steroid intervention were recorded. Audiologic response was defined as a decrease of 15 dB in 4-frequency (500, 1000, 2000, 4000 Hz) pure tone average (PTA). Audiologic recovery, or complete response, was defined as a follow-up PTA (PTA2) of ≤ 25 dB or within 10 dB of 1) baseline or 2) contralateral ear. Logistic regressions were performed to evaluate for predictive factors. A total of 403 patients (mean age 59.27 ± 15.80 years, 57.32% male) met inclusion criteria, of which 355 underwent corticosteroid intervention. The nonsteroid group had a less severe hearing deficit (median PTA1 49.38 dB vs 58.75 dB with steroid group; P < .05). Median PTA improvement was 6.25 dB with steroid therapy and 3.63 dB without (P < .05), but median PTA2 between steroid and nonsteroid users was not significantly different (42.5 dB and 38.13 dB, respectively; P = .821). Steroid intervention within 14 days was predictive of an audiologic response (odds ratio [OR] = 2.33) and recovery (OR = 2.46; both P < .05) compared with patients who did not undergo steroid therapy, whereas delayed steroid intervention was not, regardless of steroid regimen. Severe hearing loss had worse odds of audiologic response (OR = 0.40) or recovery (OR = 0.10; both P < .05) compared with mild hearing loss. Pretreatment hearing deficit and initiation of empiric steroid therapy within 14 days were associated with audiologic prognosis, independent of the corticosteroid regimen. These findings reinforce the benefit of prompt steroid intervention, while further highlighting a need for standardized measures of audiometric outcomes.
- 16 June 2025
- Published by The Permanente Federation in The Permanente Journal
- Vol. 29 (2) , 30-40
Open AccessPrognosis of Audiologic Recovery From Sudden Sensorineural Hearing Loss Following Corticosteroid Intervention: A Retrospective Chart Review Across Multiple Outcome Measures
This study aimed to evaluate associations among pretreatment hearing deficit, corticosteroid intervention, and audiologic recovery among patients presenting with sudden sensorineural hearing loss within an integrated health system. Electronic health records within a multicenter integrated health system were queried for clinical encounters with a diagnosis of sudden sensorineural hearing loss in 2021. Patient demographics, audiometric data, and therapeutic steroid intervention were recorded. Audiologic response was defined as a decrease of 15 dB in 4-frequency (500, 1000, 2000, 4000 Hz) pure tone average (PTA). Audiologic recovery, or complete response, was defined as a follow-up PTA (PTA2) of ≤ 25 dB or within 10 dB of 1) baseline or 2) contralateral ear. Logistic regressions were performed to evaluate for predictive factors. A total of 403 patients (mean age 59.27 ± 15.80 years, 57.32% male) met inclusion criteria, of which 355 underwent corticosteroid intervention. The nonsteroid group had a less severe hearing deficit (median PTA1 49.38 dB vs 58.75 dB with steroid group; P < .05). Median PTA improvement was 6.25 dB with steroid therapy and 3.63 dB without (P < .05), but median PTA2 between steroid and nonsteroid users was not significantly different (42.5 dB and 38.13 dB, respectively; P = .821). Steroid intervention within 14 days was predictive of an audiologic response (odds ratio [OR] = 2.33) and recovery (OR = 2.46; both P < .05) compared with patients who did not undergo steroid therapy, whereas delayed steroid intervention was not, regardless of steroid regimen. Severe hearing loss had worse odds of audiologic response (OR = 0.40) or recovery (OR = 0.10; both P < .05) compared with mild hearing loss. Pretreatment hearing deficit and initiation of empiric steroid therapy within 14 days were associated with audiologic prognosis, independent of the corticosteroid regimen. These findings reinforce the benefit of prompt steroid intervention, while further highlighting a need for standardized measures of audiometric outcomes.
- 25 February 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (5) , 1585-1593
Facial Feminization Surgery and Mental Health Resource Utilization: A Retrospective Institutional Review
Objective: This study aims to assess the effects of facial feminization surgery (FFS) on mental health resource utilization among patients with gender dysphoria within an integrated multicenter health care system.Study Design: A retrospective database review.Setting: An equal‐access, integrated health care system.Methods: We retrospectively analyzed the medical records of Kaiser Permanente Northern California patients who underwent FFS from 2016 to 2021 on utilization of mental health services in a large integrated health care system. Full FFS was defined as all 3 facial thirds. We compared average quarterly utilization for 12 to 24 months before FFS with quarterly utilization during 12 to 24 months of follow‐up. Patients who did not have continuous coverage for at least 12 months before and 12 months after FFS were excluded.Results: A total of 699 FFS cases were performed between 2016 and 2021, of which 478 cases were included (35.6 ± 12.3 years old, 207 [43.3%] had full FFS). Wilcoxon matched‐pairs signed‐rank tests comparing pre‐FFS and post‐FFS utilization counts showed statistically significant reductions in the number of mental health‐associated visits. Age and comorbid mental health diagnoses were significant predictors of mental health resource utilization in the pre‐FFS period. A comorbid mood or anxiety disorder was a predictor of changes in resource utilization following FFS.Conclusion: To our knowledge, this endeavor is the first utilization study of FFS conducted in the United States. FFS was associated with significantly lower utilization of mental health services in the 12‐month post‐FFS period compared to the 12‐month pre‐FFS period.
- 25 February 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (5) , 1585-1593
Facial Feminization Surgery and Mental Health Resource Utilization: A Retrospective Institutional Review
Objective: This study aims to assess the effects of facial feminization surgery (FFS) on mental health resource utilization among patients with gender dysphoria within an integrated multicenter health care system.Study Design: A retrospective database review.Setting: An equal‐access, integrated health care system.Methods: We retrospectively analyzed the medical records of Kaiser Permanente Northern California patients who underwent FFS from 2016 to 2021 on utilization of mental health services in a large integrated health care system. Full FFS was defined as all 3 facial thirds. We compared average quarterly utilization for 12 to 24 months before FFS with quarterly utilization during 12 to 24 months of follow‐up. Patients who did not have continuous coverage for at least 12 months before and 12 months after FFS were excluded.Results: A total of 699 FFS cases were performed between 2016 and 2021, of which 478 cases were included (35.6 ± 12.3 years old, 207 [43.3%] had full FFS). Wilcoxon matched‐pairs signed‐rank tests comparing pre‐FFS and post‐FFS utilization counts showed statistically significant reductions in the number of mental health‐associated visits. Age and comorbid mental health diagnoses were significant predictors of mental health resource utilization in the pre‐FFS period. A comorbid mood or anxiety disorder was a predictor of changes in resource utilization following FFS.Conclusion: To our knowledge, this endeavor is the first utilization study of FFS conducted in the United States. FFS was associated with significantly lower utilization of mental health services in the 12‐month post‐FFS period compared to the 12‐month pre‐FFS period.
- 11 February 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6)
In Response to Utilization of Artificial Intelligence in the Creation of Patient Information on Laryngology Topics
- 11 February 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (6)
In Response to Utilization of Artificial Intelligence in the Creation of Patient Information on Laryngology Topics